Aeglea BioTherapeutics, Inc. has been dropped from Nasdaq Composite Index.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.29 USD | +6.19% | +14.75% | +82.57% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+82.57% | 1.49B | |
+5.33% | 111B | |
+12.11% | 105B | |
-12.56% | 22.34B | |
-3.70% | 21.93B | |
-6.03% | 18.59B | |
-35.21% | 18.12B | |
-10.86% | 16.96B | |
+5.10% | 13.7B | |
+37.57% | 12.45B |
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- Spyre Therapeutics, Inc.(NasdaqCM: SYRE) dropped from NASDAQ Composite Index